{"nct_id":"NCT01905657","title":"Study of Two Doses of Pembrolizumab (MK-3475) Versus Docetaxel in Previously Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)","status":"COMPLETED","status_verified_date":"2021-09","start_date":"2013-08-09","start_date_type":"ACTUAL","primary_completion_date":"2015-09-30","primary_completion_date_type":"ACTUAL","completion_date":"2020-09-30","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["MRK"]}